Clal Biotechnology Industries Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Clal Biotechnology Industries Limited with three other
miscellaneous service companies in Middle East:
sales of 1.03 million Israel Shekels [US$282,885.04 ]
Redhill Biopharma Ltd
(11,658.18 Israel Shekels [US$3,208.10 ]
(43.25 million Israel Shekels [US$11.90 million]
of which 100%
was Agricultural Crops).
Clal Biotechnology Industries Limited reported sales of 31.77 million Israel Shekels (US$8.74 million)
December of 2015.
decrease of 47.6%
versus 2014, when the company's sales were 60.63 million Israel Shekels.
Contributing to the drop in overall sales was the 54.1% decline
in Medivned, from 17.26 million Israel Shekels to 7.91 million Israel Shekels.
There were also decreases in sales in
Kayortech (down 43.3% to 22.70 million Israel Shekels)
However, these declines were partially offset by the increase in sales of
Other (up 178.3% to 29.77 million Israel Shekels)
Gmida Sal (up 48.0% to 18.62 million Israel Shekels)